tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Sagimet Biosciences price target raised to $27 from $15 at JonesResearch
PremiumThe FlySagimet Biosciences price target raised to $27 from $15 at JonesResearch
2M ago
Promising Potential of Sagimet Biosciences: Buy Rating Affirmed by Positive Phase 3 Trial Results and Strategic Advancements
Premium
Ratings
Promising Potential of Sagimet Biosciences: Buy Rating Affirmed by Positive Phase 3 Trial Results and Strategic Advancements
2M ago
Sagimet Biosciences Announces Phase 3 Trial Success
Premium
Company Announcements
Sagimet Biosciences Announces Phase 3 Trial Success
2M ago
Sagimet Biosciences Reports Q1 Financial Results and Updates
PremiumCompany AnnouncementsSagimet Biosciences Reports Q1 Financial Results and Updates
2M ago
Sagimet Biosciences reports Q1 EPS (56c), consensus (69c)
Premium
The Fly
Sagimet Biosciences reports Q1 EPS (56c), consensus (69c)
2M ago
Sagimet Biosciences announces presentations at EASL Congress 2025
Premium
The Fly
Sagimet Biosciences announces presentations at EASL Congress 2025
3M ago
Promising Developments in Sagimet Biosciences: IND Clearance for TVB-3567 and Ongoing Success of Denifanstat
PremiumRatingsPromising Developments in Sagimet Biosciences: IND Clearance for TVB-3567 and Ongoing Success of Denifanstat
4M ago
Promising Pipeline and Positive Trial Data Support Buy Rating for Sagimet Biosciences
Premium
Ratings
Promising Pipeline and Positive Trial Data Support Buy Rating for Sagimet Biosciences
4M ago
Sagimet Biosciences’ Strategic Expansion into Acne Treatment with Promising FASN Inhibitor TVB-3567
Premium
Ratings
Sagimet Biosciences’ Strategic Expansion into Acne Treatment with Promising FASN Inhibitor TVB-3567
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100